NCT00688389

Brief Summary

The study will collect the blood samples from 350 healthy persons and 350 persons infected with dengue fever.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
700

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2007

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

May 28, 2008

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 2, 2008

Completed
12.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

February 28, 2019

Status Verified

February 1, 2019

Enrollment Period

13.5 years

First QC Date

May 28, 2008

Last Update Submit

February 27, 2019

Conditions

Dengue Fever

Keywords

Dengue fever, CLEC5A, Mannose receptor, DC-SIGN, NALP,decoy receptor 3 (DcR3), Toll-like receptors(TLRs),(Nod)-like receptors (NLRs)

Outcome Measures

Primary Outcomes (1)

  • 檢查肝臟、腎臟及其他生化功能，並分析宿主免疫調控及血小板變化機致

    抽血20 c.c 檢查肝臟、腎臟及其他生化功能，並分析宿主免疫調控及血小板變化機致

    2007/7/1

Study Arms (3)

healthy

Other: case/control

DF

Other: case/control

DHF

Other: case/control

Interventions

case/controlOTHER

case: infected dengue fever people control:healthy people

DFDHFhealthy

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The samples are obtained from the Kaohsiung Medical University Chung-Ho Memorial Hospital in Kaohsiung, Taiwan.

You may qualify if:

  • Clinical diagnosis of Dengue fever

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kaoshing Medical University Chung-Ho Memorial Hospital

Kaohsiung City, Taiwan

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

blood samples

MeSH Terms

Conditions

Dengue

Interventions

Case-Control Studies

Condition Hierarchy (Ancestors)

Mosquito-Borne DiseasesVector Borne DiseasesInfectionsArbovirus InfectionsVirus DiseasesFlavivirus InfectionsFlaviviridae InfectionsRNA Virus InfectionsHemorrhagic Fevers, Viral

Intervention Hierarchy (Ancestors)

Epidemiologic StudiesEpidemiologic Study CharacteristicsEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Jih-Jin Tsai, MD

CONTACT

886-7-312-1101jijits@cc.kmu.edu.tw

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2008

First Posted

June 2, 2008

Study Start

July 1, 2007

Primary Completion

December 31, 2020

Study Completion

December 31, 2020

Last Updated

February 28, 2019

Record last verified: 2019-02

Locations

TW(1)